Tonix Pharmaceuticals Holding Corp., a biopharmaceutical company with a portfolio of marketed products and a pipeline of development candidates, has officially announced the launch of TONIX ONE™, which happens to be a fully-integrated digital platform geared towards helping patients better understand and manage their migraine condition.
According to certain reports, the stated platform leverages Tonix’s strategic partnerships with UpScript Telemedicine, ProModRx, Blink Health, and a leading mobile application specializing in disease tracking, reporting and symptom management, to transform the migraine patient journey into a unified digital platform.
More on that would reveal how TONIX ONE arrives on the scene bearing an ability to conceive one intuitive, comprehensive journey for patients by offering educational resources regarding migraine and the limitations of oral medications which can sometimes lead to delayed or ineffective symptom relief.
On top of that, the platform also connects patients directly to migraine specialists via telehealth services and e-prescription requests, all for the purpose of simplifying and accelerating access to treatment.
“We developed TONIX ONE to leverage innovation and deliver a full-service digital solution that seamlessly guides patients from their migraine diary app to prescription fulfillment within hours. Our goal is not only to educate and empower patients seeking better treatment options but also to remove the barriers to care that many individuals living with migraines face,” said Scott Szymanski, Vice President of Sales and Marketing, Migraine, of Tonix Pharmaceuticals.
We referred to how Tonix collaborated with different players to reach upon its latest brainchild, but what we haven’t yet touched upon the ways in which each company contributed to the final value proposition.
Hence, starting from Gpmigraine.com, it was roped in to provide patients with valuable insights into migraine management, and it will do so by addressing the challenges of oral medications associated with gastroparesis. In essence, the company’s proprietary platform is best known for helping patients explore alternative treatments, while simultaneously empowering them to make informed decisions about their care.
Next up, we have ProModRx, who promises to provide patients with a digital solution called dRx Request, which lets you request an e-prescription from their established migraine clinician.
Another Tonix partner we must expand is UpScript Health, leading telemedicine provider in the U.S. The company’s focal segment of patients is understood to be those who do not have an established migraine clinician or would rather use telemedicine. You see, for this particular contingent, UpScript unlocks real-time access to 100’s of expert clinicians.
Beyond that, there is Blink Health, a company dedicated to revolutionizing the pharmacy experience. Using digital cutting-edge technology, the company dramatically improves patient access for branded medications.
As for the leading mobile application used by Tonix, it was to effectively empower patients suffering from headaches and migraines through data-driven insights that can come in handy for tracking, reporting, and self-management.
By providing valuable health data, the platform can tread up a long distance to accelerate diagnosis and optimize treatment options, ultimately enhancing the quality of life for people living with migraine symptoms.
“With the launch of TONIX ONE, we are further strengthening Tonix Pharmaceuticals’ position as a leader in innovation, addressing barriers and inefficiencies that stand between patients and the life-changing medications they need,” said Seth Lederman, M.D., Chief Executive Officer of Tonix Pharmaceuticals. “By offering a fully-integrated digital platform that streamlines disease state education, prescription acquisition, and fulfillment, we are enhancing access for patients while creating value across our existing portfolio, pipeline, and future business development opportunities.”
